{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:15:53Z","timestamp":1789193753049,"version":"build-2803163510"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00415-022-11507-y","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T01:02:48Z","timestamp":1671066168000},"page":"1908-1930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3988-9196","authenticated-orcid":false,"given":"Monokesh K.","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Jakir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mahns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-1392","authenticated-orcid":false,"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"11507_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fnins.2020.00579","volume":"14","author":"T Loeffler","year":"2020","unstructured":"Loeffler T, Schilcher I, Flunkert S, Hutter-Paier B (2020) Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value. Front Neurosci 14:579","journal-title":"Front Neurosci"},{"key":"11507_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572186","volume":"11","author":"MK Sen","year":"2020","unstructured":"Sen MK, Almuslehi MSM, Shortland PJ, Coorssen JR, Mahns DA (2020) Revisiting the pathoetiology of multiple sclerosis: has the tail been wagging the mouse? Front Immunol 11:572186","journal-title":"Front Immunol"},{"key":"11507_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2019.00338","volume":"10","author":"KN Varhaug","year":"2019","unstructured":"Varhaug KN, Torkildsen \u00d8, Myhr KM, Vedeler CA (2019) Neurofilament light chain as a biomarker in multiple sclerosis. Front Neurol 10:338","journal-title":"Front Neurol"},{"issue":"Pt 5","key":"11507_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/brain\/awp106","volume":"132","author":"EC Tallantyre","year":"2009","unstructured":"Tallantyre EC, B\u00f8 L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N (2009) Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 132(Pt 5):1190\u20131199","journal-title":"Brain"},{"issue":"3","key":"11507_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bpa.12516","volume":"28","author":"N Petrova","year":"2018","unstructured":"Petrova N, Carassiti D, Altmann DR, Baker D, Schmierer K (2018) Axonal loss in the multiple sclerosis spinal cord revisited. Brain Pathol 28(3):334\u2013348","journal-title":"Brain Pathol"},{"issue":"7","key":"11507_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1212\/WNL.57.7.1248","volume":"57","author":"C Bjartmar","year":"2001","unstructured":"Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57(7):1248\u20131252","journal-title":"Neurology"},{"issue":"Pt 6","key":"11507_CR7","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","volume":"123","author":"A Bitsch","year":"2000","unstructured":"Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Br\u00fcck W (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123(Pt 6):1174\u20131183","journal-title":"Brain"},{"issue":"2","key":"11507_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintor\u00e9 M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"1","key":"11507_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/1352458519901272","volume":"27","author":"B Srpova","year":"2021","unstructured":"Srpova B, Uher T, Hrnciarova T, Barro C, Andelova M, Michalak Z, Vaneckova M, Krasensky J, Noskova L, Havrdova EK, Kuhle J, Horakova D (2021) Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis. Mult Scler J 27(1):52\u201360","journal-title":"Mult Scler J"},{"key":"11507_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/1352458521993066:p.1352458521993066","author":"S Thebault","year":"2021","unstructured":"Thebault S, Bose G, Booth R, Freedman MS (2021) Serum neurofilament light in MS: the first true blood-based biomarker? Mult Scler. https:\/\/doi.org\/10.1177\/1352458521993066:p.1352458521993066","journal-title":"Mult Scler"},{"issue":"9","key":"11507_CR11","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1007\/s00415-020-09917-x","volume":"268","author":"T Williams","year":"2021","unstructured":"Williams T, Zetterberg H, Chataway J (2021) Neurofilaments in progressive multiple sclerosis: a systematic review. J Neurol 268(9):3212\u20133222","journal-title":"J Neurol"},{"issue":"2","key":"11507_CR12","first-page":"93","volume":"83","author":"CM Doherty","year":"2014","unstructured":"Doherty CM, Forbes RB (2014) Diagnostic lumbar puncture. Ulster Med J 83(2):93\u2013102","journal-title":"Ulster Med J"},{"issue":"10","key":"11507_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1046\/j.1468-2982.1998.1810697.x","volume":"18","author":"ST Vilming","year":"1998","unstructured":"Vilming ST, Kloster R (1998) Pain location and associated symptoms in post-lumbar puncture headache. Cephalalgia 18(10):697\u2013703","journal-title":"Cephalalgia"},{"issue":"973","key":"11507_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/pgmj.2006.044792","volume":"82","author":"SV Ahmed","year":"2006","unstructured":"Ahmed SV, Jayawarna C, Jude E (2006) Post lumbar puncture headache: diagnosis and management. Postgrad Med J 82(973):713\u2013716","journal-title":"Postgrad Med J"},{"issue":"4","key":"11507_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/1352458508100047","volume":"15","author":"KN Rithidech","year":"2009","unstructured":"Rithidech KN, Honikel L, Milazzo M, Madigan D, Troxell R, Krupp LB (2009) Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult Scler 15(4):455\u2013464","journal-title":"Mult Scler"},{"key":"11507_CR16","doi-asserted-by":"crossref","unstructured":"Sen MK, Almuslehi MSM, Shortland PJ, Mahns DA, Coorssen JR (2021) Proteomics of multiple sclerosis: inherent issues in defining the pathoetiology and identifying (early) biomarkers. Int J Mol Sci 22(14):7377","DOI":"10.3390\/ijms22147377"},{"issue":"13","key":"11507_CR17","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1177\/1352458519885613","volume":"26","author":"J Kuhle","year":"2020","unstructured":"Kuhle J, Plavina T, Barro C, Disanto G, Sangurdekar D, Singh CM, de Moor C, Engle B, Kieseier BC, Fisher E, Kappos L, Rudick RA, Goyal J (2020) Neurofilament light levels are associated with long-term outcomes in multiple sclerosis. Mult Scler J 26(13):1691\u20131699","journal-title":"Mult Scler J"},{"issue":"13","key":"11507_CR18","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1177\/1352458519882279","volume":"26","author":"G Bsteh","year":"2020","unstructured":"Bsteh G, Berek K, Hegen H, Teuchner B, Buchmann A, Voortman MM, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Khalil M, Berger T (2020) Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis. Mult Scler J 26(13):1682\u20131690","journal-title":"Mult Scler J"},{"issue":"13","key":"11507_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1177\/1352458519881428","volume":"26","author":"D Jakimovski","year":"2020","unstructured":"Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli \u00d6, Kuhle J, Benedict RH (2020) Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study. Mult Scler J 26(13):1670\u20131681","journal-title":"Mult Scler J"},{"key":"11507_CR20","doi-asserted-by":"crossref","unstructured":"Yuan A, Rao MV, Veeranna, Nixon RA (2017) Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol 9(4):a018309","DOI":"10.1101\/cshperspect.a018309"},{"issue":"7","key":"11507_CR21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"AR Gafson","year":"2020","unstructured":"Gafson AR, Barth\u00e9lemy NR, Bomont P, Carare RO, Durham HD, Julien JP, Kuhle J, Leppert D, Nixon RA, Weller RO, Zetterberg H, Matthews PM (2020) Neurofilaments: neurobiological foundations for biomarker applications. Brain 143(7):1975\u20131998","journal-title":"Brain"},{"issue":"1","key":"11507_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/exnr.1997.6654","volume":"148","author":"Q Zhu","year":"1997","unstructured":"Zhu Q, Couillard-Despr\u00e9s S, Julien JP (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148(1):299\u2013316","journal-title":"Exp Neurol"},{"key":"11507_CR23","doi-asserted-by":"crossref","unstructured":"Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S (2021) The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci 15:642384","DOI":"10.3389\/fnins.2021.642384"},{"issue":"2","key":"11507_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gr\u00e4ber S, Kuder-Buletta E, LaFougere C, Laske C, V\u00f6glein J, Levin J, Masters CL, Martins R, Schofield PR, Rossor MN, Graff-Radford NR, Salloway S, Ghetti B, Ringman JM, Noble JM, Chhatwal J, Goate AM, Benzinger TLS, Morris JC, Bateman RJ, Wang G, Fagan AM, McDade EM, Gordon BA, Jucker M, Allegri R, Amtashar F, Bateman R, Benzinger T, Berman S, Bodge C, Brandon S, Brooks W, Buck J, Buckles V, Chea S, Chhatwal J, Chrem P, Chui H, Cinco J, Clifford J, Cruchaga C, D\u2019Mello M, Donahue T, Douglas J, Edigo N, Erekin-Taner N, Fagan A, Farlow M, Farrar A, Feldman H, Flynn G, Fox N, Franklin E, Fujii H, Gant C, Gardener S, Ghetti B, Goate A, Goldman J, Gordon B, Graff-Radford N, Gray J, Gurney J, Hassenstab J, Hirohara M, Holtzman D, Hornbeck R, DiBari SH, Ikeuchi T, Ikonomovic S, Jerome G, Jucker M, Karch C, Kasuga K, Kawarabayashi T, Klunk W, Koeppe R, Kuder-Buletta E, Laske C, Lee J-H, Levin J, Marcus D, Martins R, Mason NS, Masters C, Maue-Dreyfus D, McDade E, Montoya L, Mori H, Morris J, Nagamatsu A, Neimeyer K, Noble J, Norton J, Perrin R, Raichle M, Ringman J, Roh JH, Salloway S, Schofield P, Shimada H, Shiroto T, Shoji M, Sigurdson W, Sohrabi H, Sparks P, Suzuki K, Swisher L, Taddei K, Wang J, Wang P, Weiner M, Wolfsberger M, Xiong C, Xu X (2019) Dominantly inherited Alzheimer, serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med 25(2):277\u2013283","journal-title":"Nat Med"},{"key":"11507_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.689938","volume":"15","author":"A Yuan","year":"2021","unstructured":"Yuan A, Nixon RA (2021) Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front Neurosci 15:689938","journal-title":"Front Neurosci"},{"key":"11507_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.935382","volume":"13","author":"S Lee","year":"2022","unstructured":"Lee S, Plavina T, Singh CM, Xiong K, Qiu X, Rudick RA, Calabresi PA, Stevenson L, Graham D, Raitcheva D, Green C, Matias M, Uzgiris AJ (2022) Development of a highly sensitive neurofilament light chain assay on an automated immunoassay platform. Front Neurol 13:935382","journal-title":"Front Neurol"},{"key":"11507_CR27","doi-asserted-by":"crossref","unstructured":"Das S, Dewit N, Jacobs D, Pijnenburg YAL, In 't Veld S, Coppens S, Quaglia M, Hirtz C, Teunissen CE, Vanmechelen E (2022) A novel neurofilament light chain ELISA validated in patients with Alzheimer's disease, frontotemporal dementia, and subjective cognitive decline, and the evaluation of candidate proteins for immunoassay calibration. Int J Mol Sci 23(13):7221","DOI":"10.3390\/ijms23137221"},{"issue":"1","key":"11507_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41598-019-54310-y","volume":"10","author":"V Lombardi","year":"2020","unstructured":"Lombardi V, Carassiti D, Giovannoni G, Lu CH, Adiutori R, Malaspina A (2020) The potential of neurofilaments analysis using dry-blood and plasma spots. Sci Rep 10(1):97","journal-title":"Sci Rep"},{"key":"11507_CR29","first-page":"168","volume":"14","author":"R Adiutori","year":"2018","unstructured":"Adiutori R, Aarum J, Zubiri I, Bremang M, Jung S, Sheer D, Pike I, Malaspina A (2018) The proteome of neurofilament-containing protein aggregates in blood. Biochem Biophys Rep 14:168\u2013177","journal-title":"Biochem Biophys Rep"},{"issue":"2","key":"11507_CR30","doi-asserted-by":"publisher","first-page":"fcac045","DOI":"10.1093\/braincomms\/fcac045","volume":"4","author":"MM Budelier","year":"2022","unstructured":"Budelier MM, He Y, Barthelemy NR, Jiang H, Li Y, Park E, Henson RL, Schindler SE, Holtzman DM, Bateman RJ (2022) A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer\u2019s disease. Brain Commun 4(2):fcac045","journal-title":"Brain Commun"},{"key":"11507_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nbd.2017.04.007","volume":"104","author":"A Brureau","year":"2017","unstructured":"Brureau A, Blanchard-Bregeon V, Pech C, Hamon S, Chaillou P, Guillemot JC, Barneoud P, Bertrand P, Pradier L, Rooney T, Schussler N (2017) NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration. Neurobiol Dis 104:73\u201384","journal-title":"Neurobiol Dis"},{"issue":"1","key":"11507_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3171\/jns.1989.70.1.0103","volume":"70","author":"N Ogata","year":"1989","unstructured":"Ogata N, Yonekawa Y, Taki W, Kannagi R, Murachi T, Hamakubo T, Kikuchi H (1989) Degradation of neurofilament protein in cerebral ischemia. J Neurosurg 70(1):103\u2013107","journal-title":"J Neurosurg"},{"issue":"25","key":"11507_CR33","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.1523\/JNEUROSCI.1081-12.2012","volume":"32","author":"A Yuan","year":"2012","unstructured":"Yuan A, Sasaki T, Kumar A, Peterhoff CM, Rao MV, Liem RK, Julien J-P, Nixon RA (2012) peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons. J Neurosci 32(25):8501\u20138508","journal-title":"J Neurosci"},{"issue":"4","key":"11507_CR34","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.08.252","volume":"336","author":"G Shaw","year":"2005","unstructured":"Shaw G, Yang C, Ellis R, Anderson K, Parker Mickle J, Scheff S, Pike B, Anderson DK, Howland DR (2005) Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun 336(4):1268\u20131277","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"11507_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/1352458520912379","volume":"27","author":"T Uher","year":"2021","unstructured":"Uher T, McComb M, Galkin S, Srpova B, Oechtering J, Barro C, Tyblova M, Bergsland N, Krasensky J, Dwyer M, Havrdova EK, Posova H, Vaneckova M, Zivadinov R, Horakova D, Kuhle J, Ramanathan M (2021) Neurofilament levels are associated with blood\u2013brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis. Mult Scler J 27(2):220\u2013231","journal-title":"Mult Scler J"},{"key":"11507_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2017.05.011","volume":"1668","author":"M Kalm","year":"2017","unstructured":"Kalm M, Bostr\u00f6m M, Sandelius \u00c5, Eriksson Y, Ek CJ, Blennow K, Bj\u00f6rk-Eriksson T, Zetterberg H (2017) Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood\u2013brain barrier permeability. Brain Res 1668:12\u201319","journal-title":"Brain Res"},{"issue":"4","key":"11507_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285613488434","volume":"6","author":"HF Harbo","year":"2013","unstructured":"Harbo HF, Gold R, Tintor\u00e9 M (2013) Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord 6(4):237\u2013248","journal-title":"Ther Adv Neurol Disord"},{"issue":"9","key":"11507_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, a.t.N. Group (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76(9):1035\u20131048","journal-title":"JAMA Neurol"},{"issue":"1","key":"11507_CR39","doi-asserted-by":"crossref","first-page":"e12141","DOI":"10.1002\/dad2.12141","volume":"13","author":"T Skillb\u00e4ck","year":"2021","unstructured":"Skillb\u00e4ck T, Blennow K, Zetterberg H, Shams S, Machado A, Pereira J, Lindberg O, Mielke MM, Zettergren A, Ryden L, Westman E, Wahlund L-O, Skoog I, Kern S (2021) Sex differences in CSF biomarkers for neurodegeneration and blood-brain barrier integrity. Alzheimer\u2019s Dement (Amsterdam, Netherlands) 13(1):e12141\u2013e12141","journal-title":"Alzheimer's Dement (Amsterdam, Netherlands)"},{"issue":"3","key":"11507_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/acn3.51305","volume":"8","author":"K Galetta","year":"2021","unstructured":"Galetta K, Deshpande C, Healy BC, Glanz B, Ziehn M, Saxena S, Paul A, Saleh F, Collins M, Gaitan-Walsh P, Castro-Mendoza P, Weiner HL, Chitnis T (2021) Serum neurofilament levels and patient-reported outcomes in multiple sclerosis. Ann Clin Transl Neurol 8(3):631\u2013638","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"11507_CR41","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/ene.13965","volume":"26","author":"JP Cuello","year":"2019","unstructured":"Cuello JP, Mart\u00ednez Gin\u00e9s ML, Kuhle J, Garc\u00eda Dom\u00ednguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Melda\u00f1a Rivera A, Goicochea Brice\u00f1o H, Garc\u00eda-Tizon Larroca S, De Le\u00f3n-Luis J, Michalak Z, Barro C, \u00c1lvarez Lafuente R, Medina Heras S, Fern\u00e1ndez Velasco JI, Tejeda-Velarde A, Dom\u00ednguez-Mozo MI, Muriel A, de Andr\u00e9s C, Villar LM (2019) Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study. Eur J Neurol 26(9):1200\u20131204","journal-title":"Eur J Neurol"},{"issue":"6","key":"11507_CR42","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P, Naegelin Y, Sch\u00e4delin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J (2017) Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol 81(6):857\u2013870","journal-title":"Ann Neurol"},{"issue":"10","key":"11507_CR43","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, Dahlke F, Tomic D, Leppert D, Kappos L (2019) Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92(10):e1007\u2013e1015","journal-title":"Neurology"},{"issue":"2","key":"11507_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40520-021-02054-z","volume":"34","author":"A Ladang","year":"2022","unstructured":"Ladang A, Kovacs S, Lengel\u00e9 L, Locquet M, Reginster J-Y, Bruy\u00e8re O, Cavalier E (2022) Neurofilament light chain concentration in an aging population. Aging Clin Exp Res 34(2):331\u2013339","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"11507_CR45","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, Benkert P, Ropele S, Enzinger C, Fazekas F, Schmidt R, Kuhle J (2020) Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun 11(1):812","journal-title":"Nat Commun"},{"issue":"3","key":"11507_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli \u00d6, Maceski A, Oechtering J, Achtnichts L, Conen D, Derfuss T, Lalive PH, Mueller C, M\u00fcller S, Naegelin Y, Oksenberg JR, Pot C, Salmen A, Willemse E, Kockum I, Blennow K, Zetterberg H, Gobbi C, Kappos L, Wiendl H, Berger K, Sormani MP, Granziera C, Piehl F, Leppert D, Kuhle J, Aeschbacher S, Barakovic M, Buser A, Chan A, Disanto G, D\u2019Souza M, Du Pasquier R, Findling O, Galbusera R, Hrusovsky K, Khalil M, Lorscheider J, Mathias A, Orleth A, Radue E-W, Rahmanzadeh R, Sinnecker T, Subramaniam S, Vehoff J, Wellmann S, Wuerfel J, Zecca C (2022) Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 21(3):246\u2013257","journal-title":"Lancet Neurol"},{"issue":"24","key":"11507_CR47","doi-asserted-by":"publisher","first-page":"25729","DOI":"10.18632\/aging.203790","volume":"13","author":"M Koini","year":"2021","unstructured":"Koini M, Pirpamer L, Hofer E, Buchmann A, Pinter D, Ropele S, Enzinger C, Benkert P, Leppert D, Kuhle J, Schmidt R, Khalil M (2021) Factors influencing serum neurofilament light chain levels in normal aging. Aging (Albany NY) 13(24):25729\u201325738","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"11507_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/acn3.50972","volume":"7","author":"A Manouchehrinia","year":"2020","unstructured":"Manouchehrinia A, Piehl F, Hillert J, Kuhle J, Alfredsson L, Olsson T, Kockum I (2020) Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. Ann Clin Transl Neurol 7(1):139\u2013143","journal-title":"Ann Clin Transl Neurol"},{"key":"11507_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104177:p.104177","author":"KZ Revendova","year":"2022","unstructured":"Revendova KZ, Zeman D, Bunganic R, Karasova K, Volny O, Bar M, Kusnierova P (2022) Serum neurofilament levels in patients with multiple sclerosis: a comparison of SIMOA and high sensitivity ELISA assays and contributing factors on ELISA levels. Multiple Scler Relat Disord. https:\/\/doi.org\/10.1016\/j.msard.2022.104177:p.104177","journal-title":"Multiple Scler Relat Disord"},{"issue":"3","key":"11507_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O, Trojano M, S\u00f8rensen PS, Reingold S, Cutter G, Reider N (2015) A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler 21(3):263\u2013281","journal-title":"Mult Scler"},{"issue":"9","key":"11507_CR51","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/jnnp-2018-319190","volume":"90","author":"S-J Martin","year":"2019","unstructured":"Martin S-J, McGlasson S, Hunt D, Overell J (2019) Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case\u2013control studies. J Neurol Neurosurg Psychiatry 90(9):1059\u20131067","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11507_CR52","doi-asserted-by":"publisher","first-page":"20350","DOI":"10.1038\/s41598-020-76990-7","volume":"10","author":"S Akamine","year":"2020","unstructured":"Akamine S, Marutani N, Kanayama D, Gotoh S, Maruyama R, Yanagida K, Sakagami Y, Mori K, Adachi H, Kozawa J, Maeda N, Otsuki M, Matsuoka T, Iwahashi H, Shimomura I, Ikeda M, Kudo T (2020) Renal function is associated with blood neurofilament light chain level in older adults. Sci Rep 10(1):20350","journal-title":"Sci Rep"},{"issue":"11","key":"11507_CR53","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1212\/01.WNL.0000036618.68674.7A","volume":"59","author":"PA Calabresi","year":"2002","unstructured":"Calabresi PA, Austin H, Racke MK, Goodman A, Choyke P, Maloni H, McFarland HF (2002) Impaired renal function in progressive multiple sclerosis. Neurology 59(11):1799\u20131801","journal-title":"Neurology"},{"issue":"1","key":"11507_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/labmed\/lmy028","volume":"50","author":"A Ruiz-Arg\u00fcelles","year":"2018","unstructured":"Ruiz-Arg\u00fcelles A, Gast\u00e9lum-Cano JM, M\u00e9ndez-Huerta MA, Rodr\u00edguez-Gallegos AB, Ruiz-Arg\u00fcelles GJ (2018) Glomerular filtration rate in patients with multiple sclerosis undergoing stem cell transplantation and treated with cyclophosphamide. Lab Med 50(1):42\u201346","journal-title":"Lab Med"},{"key":"11507_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.819010","volume":"16","author":"AA Polymeris","year":"2022","unstructured":"Polymeris AA, Helfenstein F, Benkert P, Aeschbacher S, Leppert D, Coslovsky M, Willemse E, Schaedelin S, Blum MR, Rodondi N, Reichlin T, Moschovitis G, Wuerfel J, De Marchis GM, Engelter ST, Lyrer PA, Conen D, K\u00fchne M, Osswald S, Bonati LH, Kuhle J (2022) Renal function and body mass index contribute to serum neurofilament light chain levels in elderly patients with atrial fibrillation. Front Neurosci 16:819010","journal-title":"Front Neurosci"},{"key":"11507_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2021.100044","volume":"5","author":"T Williams","year":"2021","unstructured":"Williams T, Zetterberg H, Chataway J (2021) Serum neurofilament light concentrations are not associated with renal function in secondary progressive multiple sclerosis. Biomark Neuropsychiatry 5:100044","journal-title":"Biomark Neuropsychiatry"},{"issue":"1","key":"11507_CR57","doi-asserted-by":"publisher","first-page":"19982","DOI":"10.1038\/s41598-020-77098-8","volume":"10","author":"P Altmann","year":"2020","unstructured":"Altmann P, Leutmezer F, Zach H, Wurm R, Stattmann M, Ponleitner M, Petzold A, Zetterberg H, Berger T, Rommer P, Bsteh G (2020) Serum neurofilament light chain withstands delayed freezing and repeated thawing. Sci Rep 10(1):19982","journal-title":"Sci Rep"},{"issue":"12","key":"11507_CR58","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1177\/1352458513482374","volume":"19","author":"J Kuhle","year":"2013","unstructured":"Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A, Leppert D, Giovannoni G, Kappos L (2013) A comparative study of CSF neurofilament light and heavy chain protein in MS. Mult Scler 19(12):1597\u20131603","journal-title":"Mult Scler"},{"issue":"9","key":"11507_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075091","volume":"8","author":"J Gaiottino","year":"2013","unstructured":"Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE 8(9):e75091","journal-title":"PLoS ONE"},{"issue":"10","key":"11507_CR60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14(10):577\u2013589","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"11507_CR61","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius \u00c5, Liman V, Norgren N, Blennow K, Zetterberg H (2016) Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med 54(10):1655\u20131661","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"11507_CR62","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, Piech T, Patel PP, Chang L, Rivnak AJ, Ferrell EP, Randall JD, Provuncher GK, Walt DR, Duffy DC (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28(6):595\u2013599","journal-title":"Nat Biotechnol"},{"issue":"2","key":"11507_CR63","first-page":"126","volume":"87","author":"G Disanto","year":"2016","unstructured":"Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, Evdoshenko E, Thouvenot E, Trojano M, Norgren N, Teunissen C, Kappos L, Giovannoni G, Kuhle J (2016) Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 87(2):126\u2013129","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"11507_CR64","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1212\/WNL.0000000000006902","volume":"92","author":"G Dalla Costa","year":"2019","unstructured":"Dalla Costa G, Martinelli V, Sangalli F, Moiola L, Colombo B, Radaelli M, Leocani L, Furlan R, Comi G (2019) Prognostic value of serum neurofilaments in patients with clinically isolated syndromes. Neurology 92(7):e733\u2013e741","journal-title":"Neurology"},{"key":"11507_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51355","author":"A Gauthier","year":"2021","unstructured":"Gauthier A, Viel S, Perret M, Brocard G, Casey R, Lombard C, Laurent-Chabalier S, Debouverie M, Edan G, Vukusic S, Lebrun-Fr\u00e9nay C, De S\u00e8ze J, Laplaud DA, Castelnovo G, Gout O, Ruet A, Moreau T, Casez O, Clavelou P, Berger E, Zephir H, Trouillet-Assant S, Thouvenot E (2021) Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.51355","journal-title":"Ann Clin Transl Neurol"},{"issue":"3\u20134","key":"11507_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/prca.201300053","volume":"8","author":"C Salvisberg","year":"2014","unstructured":"Salvisberg C, Tajouri N, Hainard A, Burkhard PR, Lalive PH, Turck N (2014) Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis. Proteomics Clin Appl 8(3\u20134):185\u2013194","journal-title":"Proteomics Clin Appl"},{"issue":"9","key":"11507_CR67","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","volume":"21","author":"F Meissner","year":"2022","unstructured":"Meissner F, Geddes-McAlister J, Mann M, Bantscheff M (2022) The emerging role of mass spectrometry-based proteomics in drug discovery. Nat Rev Drug Discov 21(9):637\u2013654","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"11507_CR68","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1021\/acsomega.9b03764","volume":"5","author":"S Banerjee","year":"2020","unstructured":"Banerjee S (2020) Empowering clinical diagnostics with mass spectrometry. ACS Omega 5(5):2041\u20132048","journal-title":"ACS Omega"},{"issue":"2","key":"11507_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jclinpath-2019-206269","volume":"73","author":"AWS Fung","year":"2020","unstructured":"Fung AWS, Sugumar V, Ren AH, Kulasingam V (2020) Emerging role of clinical mass spectrometry in pathology. J Clin Pathol 73(2):61\u201369","journal-title":"J Clin Pathol"},{"issue":"12","key":"11507_CR70","first-page":"1324","volume":"90","author":"T Sejbaek","year":"2019","unstructured":"Sejbaek T, Nielsen HH, Penner N, Plavina T, Mendoza JP, Martin NA, Elkjaer ML, Ravnborg MH, Illes Z (2019) Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment na\u00efve relapsing MS patients. J Neurol Neurosurg Psychiatry 90(12):1324\u20131330","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"S4","key":"11507_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/alz.045278","volume":"16","author":"X Qiu","year":"2020","unstructured":"Qiu X, Lee S, Jackson J, Zhao X, Shields A, Matias M, Uzgiris A (2020) Equivalence of serum and plasma neurofilament light chain levels using highly sensitive automated immunoassay. Alzheimers Dement 16(S4):e045278","journal-title":"Alzheimers Dement"},{"issue":"22","key":"11507_CR72","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","volume":"89","author":"L Novakova","year":"2017","unstructured":"Novakova L, Zetterberg H, Sundstr\u00f6m P, Axelsson M, Khademi M, Gunnarsson M, Malmestr\u00f6m C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J (2017) Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. Neurology 89(22):2230\u20132237","journal-title":"Neurology"},{"issue":"5","key":"11507_CR73","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000598","volume":"6","author":"S Thebault","year":"2019","unstructured":"Thebault S, Tessier DR, Lee H, Bowman M, Bar-Or A, Arnold DL, Atkins HL, Tabard-Cossa V, Freedman MS (2019) High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS. Neurol Neuroimmunol Neuroinflamm 6(5):e598","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"11507_CR74","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000271","volume":"3","author":"J Bergman","year":"2016","unstructured":"Bergman J, Dring A, Zetterberg H, Blennow K, Norgren N, Gilthorpe J, Bergenheim T, Svenningsson A (2016) Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS. Neurol Neuroimmunol Neuroinflamm 3(5):e271","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11507_CR75","doi-asserted-by":"crossref","unstructured":"Thebault S, Booth RA, Rush CA, MacLean H, Freedman MS (2021) Serum neurofilament light chain measurement in MS: hurdles to clinical translation. Front Neurosci 15(334):654942","DOI":"10.3389\/fnins.2021.654942"},{"key":"11507_CR76","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/NDT.S173280","volume":"14","author":"L Cai","year":"2018","unstructured":"Cai L, Huang J (2018) Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study. Neuropsychiatr Dis Treat 14:2241\u20132254","journal-title":"Neuropsychiatr Dis Treat"},{"key":"11507_CR77","doi-asserted-by":"crossref","unstructured":"Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S (2021) The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci 15(383)","DOI":"10.3389\/fnins.2021.642384"},{"issue":"8","key":"11507_CR78","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90(8):870\u2013881","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"S1","key":"11507_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/cen3.12346","volume":"8","author":"M Niino","year":"2017","unstructured":"Niino M, Miyazaki Y (2017) Radiologically isolated syndrome and clinically isolated syndrome. Clin Exp Neuroimmunol 8(S1):24\u201332","journal-title":"Clin Exp Neuroimmunol"},{"issue":"11","key":"11507_CR80","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/WNL.0000000000003085","volume":"87","author":"G Arrambide","year":"2016","unstructured":"Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cerme\u00f1o JC, Pic\u00f3n C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, R\u00edo J, Nos C, Tur C, Castill\u00f3 J, Vidal-Jordana A, Gal\u00e1n I, Ar\u00e9valo MJ, Auger C, Rovira A, Montalban X, Tintore M (2016) Neurofilament light chain level is a weak risk factor for the development of MS. Neurology 87(11):1076\u20131084","journal-title":"Neurology"},{"issue":"8","key":"11507_CR81","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","volume":"84","author":"R Dobson","year":"2013","unstructured":"Dobson R, Ramagopalan S, Davis A, Giovannoni G (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry 84(8):909\u2013914","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11507_CR82","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/cen3.12554","volume":"11","author":"M Teixeira","year":"2020","unstructured":"Teixeira M, Seabra M, Carvalho L, Sequeira L, Abreu P, Mendon\u00e7a T, Reis J, S\u00e1 MJ, Guimar\u00e3es J (2020) Clinically isolated syndrome, oligoclonal bands and multiple sclerosis. Clin Exp Neuroimmunol 11(1):33\u201339","journal-title":"Clin Exp Neuroimmunol"},{"issue":"2","key":"11507_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/diagnostics12020270","volume":"12","author":"AI AlTokhis","year":"2022","unstructured":"AlTokhis AI, AlAmrani A, Alotaibi A, Podlasek A, Constantinescu CS (2022) Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome and multiple sclerosis: a systematic review and meta-analysis. Diagnostics 12(2):270","journal-title":"Diagnostics"},{"issue":"1","key":"11507_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ana.25637","volume":"87","author":"KK Chung","year":"2020","unstructured":"Chung KK, Altmann D, Barkhof F, Miszkiel K, Brex PA, O\u2019Riordan J, Ebner M, Prados F, Cardoso MJ, Vercauteren T, Ourselin S, Thompson A, Ciccarelli O, Chard DT (2020) A 30-year clinical and magnetic resonance imaging observational study of multiple sclerosis and clinically isolated syndromes. Ann Neurol 87(1):63\u201374","journal-title":"Ann Neurol"},{"issue":"3","key":"11507_CR85","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O\u2019Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, St\u00fcve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"issue":"3","key":"11507_CR86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaneurol.2016.5056","volume":"74","author":"Z Xia","year":"2017","unstructured":"Xia Z, Steele SU, Bakshi A, Clarkson SR, White CC, Schindler MK, Nair G, Dewey BE, Price LR, Ohayon J, Chibnik LB, Cortese ICM, De Jager PL, Reich DS (2017) Assessment of early evidence of multiple sclerosis in a prospective study of asymptomatic high-risk family members. JAMA Neurol 74(3):293\u2013300","journal-title":"JAMA Neurol"},{"issue":"15 Supplement","key":"11507_CR87","doi-asserted-by":"crossref","first-page":"S37.003","DOI":"10.1212\/WNL.92.15_supplement.S37.003","volume":"92","author":"E Thouvenot","year":"2019","unstructured":"Thouvenot E, Demattei C, Uygunoglu U, Pittion S, Castelnovo G, de Terdonck LDT, Cohen M, Okuda D, Kantarci O, Pelletier D, Marin P, Lehmann S, Siva A, Frenay CL (2019) Neurofilament-light chain levels are predictive of on-going disease activity in radiologically isolated syndrome (S37.003). Neurology 92(15 Supplement):S37.003","journal-title":"Neurology"},{"issue":"7","key":"11507_CR88","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrn3275","volume":"13","author":"PK Stys","year":"2012","unstructured":"Stys PK, Zamponi GW, van Minnen J, Geurts JJ (2012) Will the real multiple sclerosis please stand up? Nat Rev Neurosci 13(7):507\u2013514","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"11507_CR89","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/acn3.51060","volume":"7","author":"M Rosso","year":"2020","unstructured":"Rosso M, Gonzalez CT, Healy BC, Saxena S, Paul A, Bjornevik K, Kuhle J, Benkert P, Leppert D, Guttmann C, Bakshi R, Weiner HL, Chitnis T (2020) Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. Ann Clin Transl Neurol 7(6):945\u2013955","journal-title":"Ann Clin Transl Neurol"},{"key":"11507_CR90","doi-asserted-by":"crossref","unstructured":"Huss A, Senel M, Abdelhak A, Mayer B, Kassubek J, Ludolph AC, Otto M, Tumani H (2020) Longitudinal serum neurofilament levels of multiple sclerosis patients before and after treatment with first-line immunomodulatory therapies. Biomedicines 8(9):312","DOI":"10.3390\/biomedicines8090312"},{"issue":"15 Supplement","key":"11507_CR91","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1212\/WNL.96.15_supplement.2410","volume":"96","author":"G Cutter","year":"2021","unstructured":"Cutter G, Rudick RA, De Moor C, Singh CM, Fisher E, Lublin FD, Wolinsky JS, McFarland H, Jacobson S, Naylor ML (2021) Serum neurofilament light-chain (sNfL) levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (RRMS) patients in the CombiRx trial (2410). Neurology 96(15 Supplement):2410","journal-title":"Neurology"},{"issue":"1","key":"11507_CR92","doi-asserted-by":"publisher","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","volume":"10","author":"S Thebault","year":"2020","unstructured":"Thebault S, Abdoli M, Fereshtehnejad S-M, Tessier D, Tabard-Cossa V, Freedman MS (2020) Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis. Sci Rep 10(1):10381","journal-title":"Sci Rep"},{"issue":"1","key":"11507_CR93","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000422","volume":"5","author":"KN Varhaug","year":"2018","unstructured":"Varhaug KN, Barro C, Bj\u00f8rnevik K, Myhr K-M, Torkildsen \u00d8, Wergeland S, Bindoff LA, Kuhle J, Vedeler C (2018) Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 5(1):e422","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11507_CR94","doi-asserted-by":"publisher","first-page":"175628642110019","DOI":"10.1177\/17562864211001977","volume":"14","author":"S Engel","year":"2021","unstructured":"Engel S, Protopapa M, Steffen F, Papanastasiou V, Nicolaou C, Protopapas M, Zipp F, Bittner S, Luessi F (2021) Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis. Ther Adv Neurol Disord 14:17562864211001976","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"11507_CR95","first-page":"205521731988719","volume":"5","author":"LE Baldassari","year":"2019","unstructured":"Baldassari LE, Planchon SM, Bermel RA, Nakamura K, Fisher E, Feng J, Sakaie KE, Ontaneda D, Cohen JA (2019) Serum neurofilament light chain concentration in a phase 1\/2 trial of autologous mesenchymal stem cell transplantation. Mult Scler J Exp Transl Clin 5(4):2055217319887198","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"12","key":"11507_CR96","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1177\/13524585221097296","volume":"28","author":"S Brune","year":"2022","unstructured":"Brune S, H\u00f8gest\u00f8l EA, de Rodez Benavent SA, Berg-Hansen P, Beyer MK, Leikfoss IS, Bos SD, Sowa P, Brunborg C, Andorra M, Pulido Valdeolivas I, Asseyer S, Brandt A, Chien C, Scheel M, Blennow K, Zetterberg H, Kerlero de Rosbo N, Paul F, Uccelli A, Villoslada P, Berge T, Harbo HF (2022) Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis. Mult Scler 28(12):1859\u20131870","journal-title":"Mult Scler"},{"issue":"7","key":"11507_CR97","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jnnp-2022-329020","volume":"93","author":"M Comabella","year":"2022","unstructured":"Comabella M, Sastre-Garriga J, Carbonell-Mirabent P, Fissolo N, Tur C, Malhotra S, Pareto D, Aymerich FX, R\u00edo J, Rovira A, Tintor\u00e9 M, Montalban X (2022) Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 93(7):732\u2013740","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11507_CR98","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000926","volume":"8","author":"M Saraste","year":"2021","unstructured":"Saraste M, Bezukladova S, Matilainen M, Tuisku J, Rissanen E, Sucksdorff M, Laaksonen S, Vuorimaa A, Kuhle J, Leppert D, Airas L (2021) High serum neurofilament associates with diffuse white matter damage in MS. Neurol Neuroimmunol Neuroinflamm 8(1):e926","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11507_CR99","doi-asserted-by":"publisher","first-page":"102807","DOI":"10.1016\/j.ebiom.2020.102807","volume":"56","author":"S Bittner","year":"2020","unstructured":"Bittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A, Luessi F, Berthele A, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Linker R, Heesen C, Stangel M, Wildemann B, Then Bergh F, Tackenberg B, Kuempfel T, Weber F, Zettl UK, Ziemann U, Tumani H, Groppa S, M\u00fchlau M, Lukas C, Hemmer B, Wiendl H, Gold R, Zipp F (2020) Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study. EBioMedicine 56:102807","journal-title":"EBioMedicine"},{"key":"11507_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103590","volume":"72","author":"T Uphaus","year":"2021","unstructured":"Uphaus T, Steffen F, Muthuraman M, Ripfel N, Fleischer V, Groppa S, Ruck T, Meuth SG, Pul R, Kleinschnitz C, Ellwardt E, Loos J, Engel S, Zipp F, Bittner S (2021) NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study. EBioMedicine 72:103590","journal-title":"EBioMedicine"},{"issue":"8","key":"11507_CR101","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awy154","volume":"141","author":"C Barro","year":"2018","unstructured":"Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli \u00d6, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J (2018) Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain 141(8):2382\u20132391","journal-title":"Brain"},{"issue":"23","key":"11507_CR102","doi-asserted-by":"publisher","first-page":"e2457","DOI":"10.1212\/WNL.0000000000009571","volume":"94","author":"A Manouchehrinia","year":"2020","unstructured":"Manouchehrinia A, Stridh P, Khademi M, Leppert D, Barro C, Michalak Z, Benkert P, Lycke J, Alfredsson L, Kappos L, Piehl F, Olsson T, Kuhle J, Kockum I (2020) Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis. Neurology 94(23):e2457\u2013e2467","journal-title":"Neurology"},{"key":"11507_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117079","volume":"417","author":"V Anderson","year":"2020","unstructured":"Anderson V, Bentley E, Loveless S, Bianchi L, Harding KE, Wynford-Thomas RA, Joseph F, Giovannoni G, Gnanapavan S, Robertson NP, Marta M, Tallantyre EC (2020) Serum neurofilament-light concentration and real-world outcome in MS. J Neurol Sci 417:117079","journal-title":"J Neurol Sci"},{"issue":"2","key":"11507_CR104","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ane.13037","volume":"139","author":"T Holm\u00f8y","year":"2019","unstructured":"Holm\u00f8y T, R\u00f8sj\u00f8 E, Zetterberg H, Blennow K, Lindstr\u00f8m JC, Steffensen LH, Kampman MT (2019) Vitamin D supplementation and neurofilament light chain in multiple sclerosis. Acta Neurol Scand 139(2):172\u2013176","journal-title":"Acta Neurol Scand"},{"key":"11507_CR105","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.3238:p.e193238","author":"K Bjornevik","year":"2019","unstructured":"Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW, Scher AI, Kuhle J, Ascherio A (2019) Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.3238:p.e193238","journal-title":"JAMA Neurol"},{"issue":"6578","key":"11507_CR106","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375(6578):296\u2013301","journal-title":"Science"},{"issue":"6","key":"11507_CR107","volume":"7","author":"G Allali","year":"2020","unstructured":"Allali G, Kuhle J, Breville G, Leppert D, Armand S, Lalive PH (2020) Serum neurofilament light chains in MS. Assoc Timed Up Go 7(6):e895","journal-title":"Assoc Timed Up Go"},{"issue":"8","key":"11507_CR108","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00415-020-09832-1","volume":"267","author":"F Mattioli","year":"2020","unstructured":"Mattioli F, Bellomi F, Stampatori C, Mariotto S, Ferrari S, Monaco S, Mancinelli C, Capra R (2020) Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients. J Neurol 267(8):2245\u20132251","journal-title":"J Neurol"},{"issue":"4","key":"11507_CR109","doi-asserted-by":"publisher","first-page":"fcac153","DOI":"10.1093\/braincomms\/fcac153","volume":"4","author":"T Brummer","year":"2022","unstructured":"Brummer T, Muthuraman M, Steffen F, Uphaus T, Minch L, Person M, Zipp F, Groppa S, Bittner S, Fleischer V (2022) Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers. Brain Commun 4(4):fcac153","journal-title":"Brain Commun"},{"key":"11507_CR110","doi-asserted-by":"crossref","unstructured":"Cruz-Gomez \u00c1J, Forero L, Lozano-Soto E, Cano-Cano F, Sanmartino F, Rashid-L\u00f3pez R, Paz-Exp\u00f3sito J, G\u00f3mez Ramirez JD, Espinosa-Rosso R, Gonz\u00e1lez-Rosa JJ (2021) Cortical thickness and serum NfL explain cognitive dysfunction in newly diagnosed patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 8(6):e1074","DOI":"10.1212\/NXI.0000000000001074"},{"issue":"12","key":"11507_CR111","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/acn3.638","volume":"5","author":"T Chitnis","year":"2018","unstructured":"Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, H\u00e4ring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J (2018) Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Ann Clin Transl Neurol 5(12):1478\u20131491","journal-title":"Ann Clin Transl Neurol"},{"key":"11507_CR112","doi-asserted-by":"crossref","unstructured":"Aktas O, Renner A, Huss A, Filser M, Baetge S, Stute N, Gasis M, Lepka K, Goebels N, Senel M, Graf J, Enzinger C, Pinter D, Antoch G, Turowski B, Hartung H-P, Albrecht P, Otto M, Tumani H, Penner I-K (2020) Serum neurofilament light chain. No clear relation to cognition and neuropsychiatric symptoms in stable MS. 7(6):e885","DOI":"10.1212\/NXI.0000000000000885"},{"key":"11507_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101424","volume":"36","author":"I H\u00e5kansson","year":"2019","unstructured":"H\u00e5kansson I, Johansson L, Dahle C, Vrethem M, Ernerudh J (2019) Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS. Mult Scler Relat Disord 36:101424","journal-title":"Mult Scler Relat Disord"},{"key":"11507_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102534","volume":"46","author":"L Friedova","year":"2020","unstructured":"Friedova L, Motyl J, Srpova B, Oechtering J, Barro C, Vodehnalova K, Andelova M, Noskova L, Fialov\u00e1 L, Havrdova EK, Horakova D, Benedict RH, Kuhle J, Uher T (2020) The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years. Mult Scler Relat Disord 46:102534","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"11507_CR115","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.1038\/s41598-019-43990-1","volume":"9","author":"A Abdelhak","year":"2019","unstructured":"Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M (2019) Author Correction: serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep 9(1):8433","journal-title":"Sci Rep"},{"issue":"4","key":"11507_CR116","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000749","volume":"7","author":"M-C Reinert","year":"2020","unstructured":"Reinert M-C, Benkert P, Wuerfel J, Michalak Z, Ruberte E, Barro C, Huppke P, Stark W, Kropshofer H, Tomic D, Leppert D, Kuhle J, Br\u00fcck W, G\u00e4rtner J (2020) Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 7(4):e749","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"11507_CR117","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.1038\/s41598-020-67934-2","volume":"10","author":"X Ayrignac","year":"2020","unstructured":"Ayrignac X, Le Bars E, Duflos C, Hirtz C, Maleska Maceski A, Carra-Dalli\u00e8re C, Charif M, Pinna F, Prin P, MenjotdeChampfleur N, Deverdun J, Kober T, Marechal B, Fartaria MJ, Corredor Jerez R, Labauge P, Lehmann S (2020) Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity. Sci Rep 10(1):10923","journal-title":"Sci Rep"},{"key":"11507_CR118","doi-asserted-by":"crossref","unstructured":"Tavazzi E, Jakimovski D, Kuhle J, Hagemeier J, Ozel O, Ramanathan M, Barro C, Bergsland N, Tomic D, Kropshofer H, Leppert D, Michalak Z, Lincoff N, Dwyer MG, Benedict RHB, Weinstock-Guttman B, Zivadinov R (2020) Serum neurofilament light chain and optical coherence tomography measures in MS. A longitudinal study. 7(4):e737","DOI":"10.1212\/NXI.0000000000000737"},{"key":"11507_CR119","doi-asserted-by":"crossref","unstructured":"Hemond CC, Bakshi R (2018) Magnetic resonance imaging in multiple sclerosis. Cold Spring Harb Perspect Med 8(5):a028969","DOI":"10.1101\/cshperspect.a028969"},{"issue":"5","key":"11507_CR120","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458518765666","volume":"25","author":"N Siller","year":"2019","unstructured":"Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S (2019) Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis. Mult Scler 25(5):678\u2013686","journal-title":"Mult Scler"},{"issue":"11","key":"11507_CR121","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jamaneurol.2019.2137","volume":"76","author":"E Cant\u00f3","year":"2019","unstructured":"Cant\u00f3 E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, H\u00e4ring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, Benkert P, Oksenberg JR, Kuhle J (2019) Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years. JAMA Neurol 76(11):1359\u20131366","journal-title":"JAMA Neurol"},{"issue":"11","key":"11507_CR122","doi-asserted-by":"publisher","first-page":"e2016278","DOI":"10.1001\/jamanetworkopen.2020.16278","volume":"3","author":"T Plavina","year":"2020","unstructured":"Plavina T, Singh CM, Sangurdekar D, de Moor C, Engle B, Gafson A, Goyal J, Fisher E, Szak S, Kinkel RP, Sandrock AW, Su R, Kieseier BC, Rudick RA (2020) Association of serum neurofilament light levels with long-term brain atrophy in patients with a first multiple sclerosis episode. JAMA Netw Open 3(11):e2016278\u2013e2016278","journal-title":"JAMA Netw Open"},{"key":"11507_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103099","volume":"35","author":"HH Rise","year":"2022","unstructured":"Rise HH, Brune S, Chien C, Berge T, Bos SD, Andorr\u00e0 M, Valdeolivas IP, Beyer MK, Sowa P, Scheel M, Brandt AU, Asseyer S, Blennow K, Pedersen ML, Zetterberg H, de Schotten MT, Cellerino M, Uccelli A, Paul F, Villoslada P, Harbo HF, Westlye LT, H\u00f8gest\u00f8l EA (2022) Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: a longitudinal multicenter study. Neuroimage Clin 35:103099","journal-title":"Neuroimage Clin"},{"key":"11507_CR124","doi-asserted-by":"crossref","unstructured":"Graves JS, Oertel FC, Van der Walt A, Collorone S, Sotirchos ES, Pihl-Jensen G, Albrecht P, Yeh EA, Saidha S, Frederiksen J, Newsome SD, Paul F (2022) Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders. Neurol Neuroimmunol Neuroinflamm 9(2):e1126","DOI":"10.1212\/NXI.0000000000001126"},{"key":"11507_CR125","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000200778","author":"ES Sotirchos","year":"2022","unstructured":"Sotirchos ES, Vasileiou ES, Filippatou AG, Fitzgerald KC, Smith MD, Lord HN, Kalaitzidis G, Lambe J, Duval A, Prince JL, Mowry EM, Saidha S, Calabresi PA (2022) Association of serum neurofilament light chain with inner retinal layer thinning in multiple sclerosis. Neurology. https:\/\/doi.org\/10.1212\/wnl.0000000000200778","journal-title":"Neurology"},{"key":"11507_CR126","doi-asserted-by":"crossref","unstructured":"Lin TY, Vitkova V, Asseyer S, Martorell Serra I, Motamedi S, Chien C, Ditzhaus M, Papadopoulou A, Benkert P, Kuhle J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU, Zimmermann HG (2021) Increased serum neurofilament light and thin ganglion cell-inner plexiform layer are additive risk factors for disease activity in early multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 8(5):e1051","DOI":"10.1212\/NXI.0000000000001051"},{"key":"11507_CR127","doi-asserted-by":"publisher","first-page":"175628642110034","DOI":"10.1177\/17562864211003478","volume":"14","author":"CB Seitz","year":"2021","unstructured":"Seitz CB, Steffen F, Muthuraman M, Uphaus T, Kr\u00e4mer J, Meuth SG, Albrecht P, Groppa S, Zipp F, Bittner S, Fleischer V (2021) Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis. Ther Adv Neurol Disord 14:17562864211003478","journal-title":"Ther Adv Neurol Disord"},{"key":"11507_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24148","author":"MK Sen","year":"2022","unstructured":"Sen MK, Mahns DA, Coorssen JR, Shortland PJ (2022) The roles of microglia and astrocytes in phagocytosis and myelination: insights from the cuprizone model of multiple sclerosis. Glia. https:\/\/doi.org\/10.1002\/glia.24148","journal-title":"Glia"},{"issue":"8","key":"11507_CR129","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1177\/1352458517715132","volume":"24","author":"F Piehl","year":"2018","unstructured":"Piehl F, Kockum I, Khademi M, Blennow K, Lycke J, Zetterberg H, Olsson T (2018) Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod. Mult Scler 24(8):1046\u20131054","journal-title":"Mult Scler"},{"issue":"19","key":"11507_CR130","doi-asserted-by":"publisher","first-page":"e1898","DOI":"10.1212\/WNL.0000000000012752","volume":"97","author":"C Bridel","year":"2021","unstructured":"Bridel C, Leurs CE, van Lierop Z, van Kempen ZLE, Dekker I, Twaalfhoven HAM, Moraal B, Barkhof F, Uitdehaag BMJ, Killestein J, Teunissen CE (2021) Serum Neurofilament light association with progression in natalizumab-treated patients with relapsing-remitting multiple sclerosis. Neurology 97(19):e1898\u2013e1905","journal-title":"Neurology"},{"issue":"1","key":"11507_CR131","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001102","volume":"9","author":"M Bock","year":"2022","unstructured":"Bock M, Steffen F, Zipp F, Bittner S (2022) Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 9(1):e1102","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11507_CR132","doi-asserted-by":"crossref","unstructured":"Fissolo N, Pignolet B, Rio J, Vermersch P, Ruet A, deS\u00e8ze J, Labauge P, Vukusic S, Papeix C, Martinez-Almoyna L, Tourbah A, Clavelou P, Moreau T, Pelletier J, Lebrun-Frenay C, Bourre B, Defer G, Montalban X, Brassat D, Comabella M (2021) Serum neurofilament levels and pml risk in patients with multiple sclerosis treated with natalizumab. Neurol Neuroimmunol Neuroinflamm 8(4):e1003","DOI":"10.1212\/NXI.0000000000001003"},{"key":"11507_CR133","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221108080:p.13524585221108080","author":"M Johnsson","year":"2022","unstructured":"Johnsson M, Farman HH, Blennow K, Zetterberg H, Malmestr\u00f6m C, Axelsson M, Lycke J (2022) No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab. Mult Scler. https:\/\/doi.org\/10.1177\/13524585221108080:p.13524585221108080","journal-title":"Mult Scler"},{"issue":"4","key":"11507_CR134","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/13524585211032348","volume":"28","author":"J Kuhle","year":"2022","unstructured":"Kuhle J, Daizadeh N, Benkert P, Maceski A, Barro C, Michalak Z, Sormani MP, Godin J, Shankara S, Samad TA, Jacobs A, Chung L, R\u04e7sch N, Kaiser C, Mitchell CP, Leppert D, Havari E, Kappos L (2022) Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS. Mult Scler 28(4):573\u2013582","journal-title":"Mult Scler"},{"issue":"1","key":"11507_CR135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/ane.13185","volume":"141","author":"J Smolders","year":"2020","unstructured":"Smolders J, Mimpen M, Oechtering J, Damoiseaux J, van den Ouweland J, Hupperts R, Kuhle J (2020) Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis. Acta Neurol Scand 141(1):77\u201380","journal-title":"Acta Neurol Scand"},{"key":"11507_CR136","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520972573:p.1352458520972573","author":"PA Calabresi","year":"2020","unstructured":"Calabresi PA, Arnold DL, Sangurdekar D, Singh CM, Altincatal A, de Moor C, Engle B, Goyal J, Deykin A, Szak S, Kieseier BC, Rudick RA, Plavina T (2020) Temporal profile of serum neurofilament light in multiple sclerosis: implications for patient monitoring. Mult Scler. https:\/\/doi.org\/10.1177\/1352458520972573:p.1352458520972573","journal-title":"Mult Scler"},{"key":"11507_CR137","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520986956:p.1352458520986956","author":"RJ Fox","year":"2021","unstructured":"Fox RJ, Raska P, Barro C, Karafa M, Konig V, Bermel RA, Chase M, Coffey CS, Goodman AD, Klawiter EC, Naismith RT, Kuhle J (2021) Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458520986956:p.1352458520986956","journal-title":"Mult Scler"},{"key":"11507_CR138","doi-asserted-by":"crossref","unstructured":"Williams TE, Holdsworth KP, Nicholas JM, Eshaghi A, Katsanouli T, Wellington H, Heslegrave A, Zetterberg H, Frost C, Chataway J (2022) Assessing neurofilaments as biomarkers of neuroprotection in progressive multiple sclerosis. From the MS-STAT randomized controlled trial. 9(2):e1130","DOI":"10.1212\/NXI.0000000000001130"},{"issue":"8","key":"11507_CR139","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1177\/1352458511434607","volume":"18","author":"MT Kampman","year":"2012","unstructured":"Kampman MT, Steffensen LH, Mellgren SI, J\u00f8rgensen L (2012) Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler 18(8):1144\u20131151","journal-title":"Mult Scler"},{"issue":"20","key":"11507_CR140","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","volume":"93","author":"R Hupperts","year":"2019","unstructured":"Hupperts R, Smolders J, Vieth R, Holm\u00f8y T, Marhardt K, Schluep M, Killestein J, Barkhof F, Beelke M, Grimaldi LME (2019) Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon \u03b2-1a. Neurology 93(20):e1906\u2013e1916","journal-title":"Neurology"},{"key":"11507_CR141","doi-asserted-by":"crossref","unstructured":"Simr\u00e9n J, Andreasson U, Gobom J, Suarez Calvet M, Borroni B, Gillberg C, Nyberg L, Ghidoni R, Fernell E, Johnson M, Depypere H, Hansson C, Jonsdottir IH, Zetterberg H, Blennow K (2022) Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years. Brain Commun 4(4):fcac174","DOI":"10.1093\/braincomms\/fcac174"},{"key":"11507_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102666","volume":"47","author":"C Bridel","year":"2021","unstructured":"Bridel C, Verberk IMW, Heijst JJA, Killestein J, Teunissen CE (2021) Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients. Mult Scler Relat Disord 47:102666","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"11507_CR143","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2020-000063","volume":"2","author":"T Sejbaek","year":"2020","unstructured":"Sejbaek T, Mendoza JP, Penner N, Madsen JS, Olsen DA, Illes Z (2020) Comparison of neurofilament light chain results between two independent facilities. BMJ Neurol Open 2(2):e000063","journal-title":"BMJ Neurol Open"},{"issue":"8","key":"11507_CR144","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","volume":"16","author":"LM Byrne","year":"2017","unstructured":"Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, Scahill RI, Tabrizi SJ, Zetterberg H, Langbehn D, Wild EJ (2017) Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis. Lancet Neurol 16(8):601\u2013609","journal-title":"Lancet Neurol"},{"issue":"2","key":"11507_CR145","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","volume":"90","author":"F Verde","year":"2019","unstructured":"Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, Tumani H, von Arnim CAF, Dorst J, Feneberg E, Mayer B, M\u00fcller H-P, Gorges M, Rosenbohm A, Volk AE, Silani V, Ludolph AC, Otto M (2019) Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 90(2):157\u2013164","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"11507_CR146","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, Schott JM, Fox NC, Warren JD, Zetterberg H (2016) Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 87(13):1329\u20131336","journal-title":"Neurology"},{"issue":"3","key":"11507_CR147","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","volume":"86","author":"J Kuhle","year":"2015","unstructured":"Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu CH, Dobson R, Disanto G, Norgren N, Nissim A, Kappos L, Hurlbert J, Yong VW, Giovannoni G, Casha S (2015) Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry 86(3):273\u2013279","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"11507_CR148","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","volume":"90","author":"\u00c5 Sandelius","year":"2018","unstructured":"Sandelius \u00c5, Zetterberg H, Blennow K, Adiutori R, Malaspina A, Laura M, Reilly MM, Rossor AM (2018) Plasma neurofilament light chain concentration in the inherited peripheral neuropathies. Neurology 90(6):e518\u2013e524","journal-title":"Neurology"},{"issue":"8","key":"11507_CR149","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","volume":"254","author":"S Abdulle","year":"2007","unstructured":"Abdulle S, Mellgren \u00c5, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gissl\u00e9n M (2007) CSF neurofilament protein (NFL)\u2014a marker of active HIV-related neurodegeneration. J Neurol 254(8):1026\u20131032","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11507-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T08:47:33Z","timestamp":1728550053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11507-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":149,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["11507"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11507-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"24 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}